Browse All

Current Filters

CLEAR FILTER x

TITLE

Fixed Cycle and Every-Other-Week Dosing of Intravenous Efgartigimod for Generalized Myasthenia Gravis: Part B of ADAPT NXT

Author:Gwathmey, Kelly   Bril, Vera   Habib, Ali A.   Claeys, Kristl G.   Hussain, Yessar   Sahagian, Gregory   Cortés-Vicente, Elena   Brauer, Edward   Guptill, Jeff   Gelinas, Deborah   Liu, Li   Jimenez, Rosa H.   Masschaele, Delphine   Mantegazza, Renato   Meisel, Andreas   Sun, Fang   Att,   

Session Name:P1: Neuromuscular and Clinical Neurophysiology (EMG): Myasthenia Gravis 1  

Topic:Neuromuscular and Clinical Neurophysiology (EMG)  

Program Number:P1.004  

Author Institution:Austin Neuromuscular Center, Austin, TX  argenx, Ghent, Belgium  Charité – Universitätsmedizin Berlin, Berlin, Germany  

Evaluating the Comparative Effectiveness of Emerging Immunomodulatory Therapies for Patients with Generalized Myasthenia Gravis

Author:Smith, A. Gordon   Wolfe, Gil   Habib, Ali   Qi, Cynthia   Yang, Hongbo   Du, Mandy   Chen, Xin   Gelinas, Deborah   Brauer, Edward   Phillips, Glenn   

Session Name:P1: Neuromuscular and Clinical Neurophysiology (EMG): Myasthenia Gravis 1  

Topic:Neuromuscular and Clinical Neurophysiology (EMG)  

Program Number:P1.033  

Author Institution:Virginia Commonwealth University, Richmond, VA  Jacobs School of Medicine and Biomedical Sciences, Buffalo, NY  University of California, Irvine, Orange, CA  argenx, Boston, MA